Veeda Clinical Research Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2004.
2004 Ahmedabad, Gujarat, India Active
Last Updated:
About Veeda Clinical Research Limited

Veeda Clinical Research Limited, a active public limited company, was established on 23 April 2004 in Ahmedabad, Gujarat, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100GJ2004PLC044023. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹36.44 Cr and a paid-up capital of ₹13.16 Cr.

Formerly known as Clinisearch Labs Private Limited, Veeda Clinical Research Private Limited. It upholds a compliant status. Employing 902 professional, Its leadership includes Nitin Jagannath Deshmukh (Director), Jeanne Taylor Hecht (Director), Vivek Chhachhi (Nominee Director). Past directors included Snehal Shah, Apurva Bhupendra Shah, Ajay Tandon. It holds ₹679.66 Cr open charges and ₹443.46 Cr settled loans. Its latest AGM occurred on 16 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shivalik Plaza-A-,2Nd Floor Opp Ahmedabad Management Association Amb, Awadi, Ahmedabad, Gujarat, 380015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100GJ2004PLC044023

  • Registration Number

    044023

  • Incorporation Date

    23 April 2004

  • Authorized Capital

    ₹36.44 Cr

  • Paid-Up Capital

    ₹13.16 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 36.44 Cr
  • Paid Up Capital ₹ 13.16 Cr
  • Company Age 21 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 679.66 Cr
  • Satisfied Charges ₹ 443.46 Cr
  • Revenue Growth **** -4.03%
  • Profit Growth **** -88.22%
  • Ebitda **** -48.62%
  • Net Worth 71.16%
  • Total Assets **** 57.34%
Company report

Veeda Clinical Research Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Veeda Clinical Research Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Veeda Clinical Research Limited?
Current Directors
Name Designation Appointment Date Status
Nitin Jagannath Deshmukh Director 01 Jul 2021 Current
Jeanne Taylor Hecht Director 01 Jul 2021 Current
Vivek Chhachhi Nominee Director 21 Nov 2018 Current
Tanushree Akshay Agarwal Nominee Director 09 May 2024 Current
Shankarappa Nagaraja Vinaya Babu Director 16 Jul 2021 Current
Rakesh Bhartia Director 01 Jul 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Aug 2008 Past
Pramod Abcsdd Director 03 Jan 2025 Past
Pramod Abcsdd Whole-Time Director 25 May 2020 Past
Pramod Abcsdd Additional Director 30 May 2024 Past
Pramod Abcsdd Alternate Director 26 Oct 2020 Past
Pramod Abcsdd Director 15 Sep 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Veeda Clinical Research.

Veeda Clinical Research Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 4.03% decrease. The company also saw a substantial fall in profitability, with a 88.22% decrease in profit. The company's net worth Soared by an impressive increase of 71.16%.

Veeda Clinical Research revenue growth over time
Veeda Clinical Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-4.03%
*******
*******
*******
*******
Revenue from Operations
*******
-6.99%
*******
*******
*******
*******
Total Assets
*******
57.34%
*******
*******
*******
*******
Profit or Loss
*******
-88.22%
*******
*******
*******
*******
Net Worth
*******
71.16%
*******
*******
*******
*******
EBITDA
*******
-48.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Veeda Clinical Research?

In 2024, Veeda Clinical Research had a promoter holding of 35.32% and a public holding of 64.68%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,796,588,093.00

Satisfied Charges

₹4,434,551,835.00

Charges Breakdown by Lending Institutions
  • Others : 656.30 Cr
  • Axis Bank Limited : 20.00 Cr
  • Hdfc Bank Limited : 3.36 Cr
Latest Charge Details
Date Lender Amount Status
12 Dec 2025 Others ₹432.81 Cr Open
13 Aug 2025 Hdfc Bank Limited ₹3.36 Cr Open
05 Feb 2025 Others ₹218.49 Cr Open
24 Dec 2022 Others ₹5.00 Cr Open
28 Mar 2018 Axis Bank Limited ₹20.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Veeda Clinical Research?

Veeda Clinical Research has a workforce of 902 employees as of Sep 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Veeda Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veeda Clinical Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Veeda Clinical Research
Recent Activity within the Organization
  • Director Appointment

    The activity Binoy Hasmukh Gardi was appointed as a Ceo was appointed as a Ceo on 27 Jan 2026 & has been associated with this company since 24 days . was completed.

  • Director Appointment

    Binoy Hasmukh Gardi was appointed as a Additional Director was appointed as a Additional Director on 19 Jan 2026 & has been associated with this company since 1 month 1 day . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 432.81 Cr with Charge ID 101198104 was registered on 12 Dec 2025. was documented.

  • Charges

    Progress on A charge registered on 28 Mar 2025 via Charge ID 101071089 with Others was fully satisfied on 29 Oct 2025. was documented.

  • Annual General Meeting

    Veeda Clinical Research Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 3.36 Cr with Charge ID 101139776 was registered on 13 Aug 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Veeda Clinical Research Limited?

The CIN of Veeda Clinical Research Limited is U73100GJ2004PLC044023.

Where is Veeda Clinical Research Limited headquartered?

Veeda Clinical Research Limited is headquartered at Shivalik Plaza-A-,2Nd Floor Opp Ahmedabad Management Association Amb, Awadi, Ahmedabad, Gujarat, 380015.

When was Veeda Clinical Research Limited incorporated?

Veeda Clinical Research Limited was incorporated on 23 April 2004.

Who are the current directors of Veeda Clinical Research Limited?
What is the primary industry of Veeda Clinical Research Limited?

The primary industry of Veeda Clinical Research Limited is Professional, Scientific And Technical.

Is Veeda Clinical Research Limited a listed company?

Veeda Clinical Research Limited is unlisted.

What is the capital structure of Veeda Clinical Research Limited?

The authorized capital of Veeda Clinical Research Limited is ₹36.44 Cr, and the paid-up capital is ₹13.16 Cr.

What is the compliance status of Veeda Clinical Research Limited?

The compliance status of Veeda Clinical Research Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available